HYDROCHLOROTHIAZIDE ( DrugBank: Hydrochlorothiazide )


4 diseases
IDDisease name (Link within this page)Number of trials
13Multiple sclerosis/Neuromyelitis optica1
67Polycystic kidney disease2
225Congenital nephrogenic diabetes insipidus2
235Hypoparathyroidism2

13. Multiple sclerosis/Neuromyelitis optica


Clinical trials : 3,340Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

67. Polycystic kidney disease


Clinical trials : 221Drugs : 212 - (DrugBank : 55) / Drug target genes : 40 - Drug target pathways : 151 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

225. Congenital nephrogenic diabetes insipidus


Clinical trials : 15Drugs : 48 - (DrugBank : 18) / Drug target genes : 31 - Drug target pathways : 65 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

235. Hypoparathyroidism


Clinical trials : 88Drugs : 107 - (DrugBank : 24) / Drug target genes : 5 - Drug target pathways : 7 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries